Literature DB >> 11115775

Homologous and heterologous down-regulation of leptin receptor messenger ribonucleic acid in rat adrenal gland.

M Tena-Sempere1, L Pinilla, L C González, F F Casanueva, C Diéguez, E Aguilar.   

Abstract

Leptin, the adipocyte-produced hormone that plays a key role in body weight homeostasis, has recently been found to be involved in the regulation of the hypothalamic-pituitary-adrenal axis. Moreover, reciprocal interactions between leptin and glucocorticoids have been described. In the present communication, two different strategies were undertaken to explore the mode of action of leptin in the direct control of rat adrenal function. First, a synthetic peptide approach demonstrated that the inhibitory effect of leptin on basal and ACTH-stimulated corticosterone secretion in vitro is, at least partially, mapped to a domain of the native protein between amino acids 116 and 130, i.e. an area of the molecule also relevant in terms of regulation of food intake and endocrine control. Secondly, semi-quantitative RT-PCR analysis indicated a complex pattern of adrenal leptin receptor (Ob-R) mRNA expression, with predominant expression of the Ob-Ra and Ob-Rb isoforms, as well as moderate levels of the Ob-Rc and Ob-Rf variants, whereas negligible signals for the Ob-Re isoform were detected. Interestingly, such an expression pattern appeared hormonally regulated as exposure to human recombinant leptin (10(-7 )M) or ACTH (10(-7 )M) significantly decreased Ob-R isoform mRNA expression. Indeed, dose-dependent ligand-induced Ob-Ra and Ob-Rb mRNA down-regulation was further confirmed by adrenal stimulation with increasing concentrations (10(-9)-10(-5 )M) of the active leptin fragment, leptin 116-130 amide. Overall, our results provide evidence for a novel regulatory step at the level of Ob-R mRNA expression in the interplay between ACTH and leptin for the tuning of rat adrenal corticosterone secretion. Furthermore, our data showing down-regulation of Ob-R mRNA expression by its cognate ligand may well be relevant to leptin physiology and its alteration in various disease states.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115775     DOI: 10.1677/joe.0.1670479

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  7 in total

1.  Leptin alters adrenal responsiveness by decreasing expression of ACTH-R, StAR, and P450c21 in hypoxemic fetal sheep.

Authors:  Yixin Su; Luke C Carey; James C Rose; Victor M Pulgar
Journal:  Reprod Sci       Date:  2012-04-25       Impact factor: 3.060

Review 2.  Neuroendocrine effects of leptin.

Authors:  F P Pralong; R C Gaillard
Journal:  Pituitary       Date:  2001 Jan-Apr       Impact factor: 4.107

3.  Analysis of angiotensin II- and ACTH-driven mineralocorticoid functions and omental adiposity in a non-genetic, hyperadipose female rat phenotype.

Authors:  Mario Perelló; Gloria Cónsole; Rolf C Gaillard; Eduardo Spinedi
Journal:  Endocrine       Date:  2010-04-13       Impact factor: 3.633

4.  Nature of changes in adrenocortical function in chronic hyperleptinemic female rats.

Authors:  Mario Perelló; Griselda Moreno; Gisela Camihort; Georgina Luna; Gloria Cónsole; Rolf C Gaillard; Eduardo Spinedi
Journal:  Endocrine       Date:  2004-07       Impact factor: 3.633

5.  Antenatal glucocorticoid exposure enhances the inhibition of adrenal steroidogenesis by leptin in a sex-specific fashion.

Authors:  Yixin Su; Luke C Carey; James C Rose; Victor M Pulgar
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-04-30       Impact factor: 4.310

Review 6.  Nutritional regulation of leptin signaling.

Authors:  Catherine Ribiere; Charles Plut
Journal:  Curr Hypertens Rep       Date:  2005-02       Impact factor: 5.369

7.  Leptin receptor in the chicken ovary: potential involvement in ovarian dysfunction of ad libitum-fed broiler breeder hens.

Authors:  Sandrine Cassy; Sonia Metayer; Sabine Crochet; Nicole Rideau; Anne Collin; Sophie Tesseraud
Journal:  Reprod Biol Endocrinol       Date:  2004-10-08       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.